Antibiotics and Antibiotic Resistance - NDPIA/IBA course -

Similar documents
NDPIA/IBA course on Antibiotics and Antibiotic Resistance at Hjortviken Konferens, November 2018 Preliminary programme

What is the problem? Latest data on antibiotic resistance

NEWSLETTER 1 MARCH Produced by CSO-MOH IL

ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS

Antimicrobial agents. are chemicals active against microorganisms

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Summary of the latest data on antibiotic consumption in the European Union

Summary of the latest data on antibiotic consumption in the European Union

Antibiotic Discovery and Development

GLOBAL CONFERENCE Global elimination of dog-mediated human rabies The Time Is Now

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

WHO perspective on antimicrobial resistance

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Mechanisms and Pathways of AMR in the environment

Selection of antibiotic resistance in the environment

Assembly Hall/Festival Hall, University of Bonn, Germany

Assembly Hall/Festival Hall, University of Bonn, Germany

ASSEMBLY HALL/FESTIVAL HALL, UNIVERSITY OF BONN, GERMANY

Antimicrobial Resistance

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

Framework for monitoring antibiotic content and antibiotic resistance in the Danube Delta - the EnviroAMR project -

European Medicines Agency role and experience on antimicrobial resistance

Overview of antibiotic combination issues.

Global spread - Antibiotic resistance a critical sustainability question 2/14/2018. Managing resistance is in everyones interest

Mechanism of antibiotic resistance

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

WHO efforts to reduce the impact on public and animal health of antibiotic use in animals. Dr Danilo Lo Fo Wong Senior Adviser AMR

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Antimicrobials & Resistance

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Antimicrobial Resistance Initiative

9: Coffee Break. 10:00-11: Spatial Risk Mapping (Thomas Van Boekel) 11:00-12: Dynamic Bayesian Network (Yrjo Grohn)

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

An#bio#cs and challenges in the wake of superbugs

Antimicrobial consumption

Quelle politique antibiotique pour l Europe? Dominique L. Monnet

Infection control in equine breeding farms

Health Service Executive Parkgate St. Business Centre, Dublin 8 Tel:

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Global Conference on Rabies Control: Towards Sustainable Prevention at the Source

Scientific Program. 08:30 Phylogenomic transduction networks reveal genetic barriers for phagemediated lateral gene transfer Tal Dagan, Germany

Antibiotic resistance: the rise of the superbugs

DR. BASHIRU BOI KIKIMOTO

INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE

WELCOME International Meeting on Emerging Diseases and Surveillance 2007

Antimicrobial consumption

Antimicrobial resistance (EARS-Net)

Antibacterial susceptibility testing

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

GHSA Prevent-1 (AMR) road map: Progress and implementation plan Dr. Anders Tegnell, Ministry of Health and Social Affairs, Sweden

What is antimicrobial resistance?

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Antimicrobials. Antimicrobials

Middle East & Eastern Europe Rabies Expert Bureau Meeting

What is multidrug resistance?

Antimicrobial agents

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate

EUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins

12 th Biennial STVM Conference 2014

Introduction to Pharmacokinetics and Pharmacodynamics

Microbiology ( Bacteriology) sheet # 7

Prevention and control of antimicrobial resistance in healthcare settings: raising awareness about best practices

CO-ACTION. Prof.dr. J.W. Mouton. Note : some technical and all results slides were removed. JPIAMR JWM Paris JWM Paris 2017

Curricular Components for Infectious Diseases EPA

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

Antibiotic Resistance and Hospital-Acquired Infection Prof. Carl T. Bergstrom

Day 0: Tuesday 3 December Day 1: Wednesday 4 December 2013 Opening Session

Antimicrobial Resistance and Prescribing

Mike Apley Kansas State University

CITIZENS JURY ON ANTIMICROBIAL STEWARDSHIP PROGRAMME

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

2017 NAMI Meat Industry Summit, San Diego, CA April 3-5, Keith E. Belk

Antimicrobial use in poultry: Emerging public health problem

Game Meat Hygiene in Focus Conference

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Day 0: Tuesday 3 December Day 1: Wednesday 4 December 2013 Opening Session

Tackling the need for new antibacterial drugs

NOVEMBER 9 10 INFORMATIONSHEET EXHIBITORS

Typhoid fever - priorities for research and development of new treatments

Principles of Antimicrobial therapy

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

Antimicrobial use in animals: OIE collection of data on antimicrobial agents used in animals (2015)

OIE initiative establishing a global database on consumption of antimicrobials for animals: state of play

بسم هللا الرحمن الرحيم

EC Workshop on scientific advice from AMEG

Norwegian policies to address antimicrobial resistance

OIE List of Antimicrobial Agents of Veterinary Importance and OIE Standards and Activities

Antibiotics & Resistance

WVA/WMA GLOBAL CONFERENCE ON ONE HEALTH

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE AND COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE

Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health

Transcription:

Antibiotics and Antibiotic Resistance - NDPIA/IBA course - 26-30 November 2018 Hjortviken Konferens, Gothenburg, Sweden National Graduate School in Infection Biology and Antimicrobials

Program Monday 26 November 10.00 - Registration and poster mounting 12.15-13.15 Lunch 13.15-14.15 Welcome and one-minute introductions by course participants Åke Forsberg, NDPIA, MIMS, UCMR, Umeå University Chair person: Åke Forsberg 14.15-15.15 An introduction to the evolution, spread, and management of antibiotic resistance Diarmaid Hughes, Uppsala University, Sweden / Joakim Larsson, CARe, University of Gothenburg, Sweden / Arnfinn Sundsfjord, University of Tromsö, Norway 15.15-15.45 Coffee break Chair person: Michael Koomey 15.45-17.15 Introductory lectures continued Antibiotic resistance in Neisseria gonorrhoeae Yonatan Grad, Harvard TH Chan School of Public Health, USA M. tuberculosis resistance Tone Tønjum, Oslo University, Oslo University Hospital, Norway 17.15-18.30 Presentations of NDPIA/IBA and research centres followed by predinner mingle Michael Koomey, University of Oslo, Norway (IBA) Åke Forsberg, Umeå University, Sweden (UCMR/MIMS/NDPIA) Carl-Fredrik Flach, University of Gothenburg, Sweden (CARe) Diarmaid Hughes, Uppsala University, Sweden (UAC) Arnfinn Sundsfjord, University of Tromsö, Norway (CANS) 18.30-20.00 Dinner Chair person: Michael Koomey 20.15 - Evening talk Ethics in antibiotic resistance management Christian Munthe, CARe, University of Gothenburg Gothenburg, Sweden 3

Program Tuesday 27 November Modes of action and mechanisms of resistance of existing classes: Ribosomes Chair persons: Örjan Samuelsen and Michael Koomey 08.30-09.15 Ribosome structure and function Nora Vázquez-Laslop, Center for Biomolecular Sciences, University of Illinois at Chicago, Chicago, USA 09.15-10.00 Development of next generation tetracyclines Patricia Bradford, Antimicrobial Development Specialists, LLC, Nyack, NY, USA 10.00-10.20 Coffee break 10.20-11.05 Macrolides-Lincosamides-Streptogramins, pleuromutilins, oxazolidinones Nora Vazquez-Laslop, University of Illinois at Chicago, USA Modes of action and mechanisms of resistance of existing classes: Cell wall Chair persons: Nora Vazquez-Laslop and Raimonda Viburiene 11.05-11.50 Cell wall structure, biosynthesis, and targets Felipe Cava, MIMS, UCMR, Umeå University, Sweden 11:50-12:45 Lunch 12:45-13:45 Poster session I - no. 1-14 3 poster walks in groups (5 min presentation + 5 min questions) in parallel: 1-5, 6-10, 11-14 - see Poster Sessions (page 82-85) 13.45-14.30 Free poster viewing of posters of the day 14.30-14.45 Coffee break 14.45-15.30 β-lactams and β-lactamases Örjan Samuelsen, University of Tromsø, Norway 15.30-16.15 Overview of new beta-lactam/beta-lactam inhibitor combinations Patricia Bradford, Antimicrobial Development Specialists, LLC, US 16.15-16.30 Break Chair persons: Patricia Bradford and Åke Forsberg 16.30-17.15 Resistance inhibitors Pål Rongved, University of Oslo, Norway 17.15-18.00 Glycopeptides, lipopeptides, lipoglycopeptides Gerry Wright, McMaster University, Canada 18.15-20.00 Dinner Chair person: Åke Forsberg 20.00 - Evening talk: EU Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) and Swedish Research Council (VR) programme for funding AMR research 2019-2028 Patriq Fagerstedt, Swedish Research Council (VR), Sweden 4

Wednesday 28 November Program Modes of action and mechanisms of resistance of existing classes: Nucleic acid synthesis, replication, transcription Chair persons: Didier Mazel and Disa Larsson Hammarlöf 08.30-09.15 Aminoglycosides: Mode of action and resistance Gerry Wright, McMaster University, Canada 09.15-10.00 Rifampicin Gerry Wright, McMaster University, Canada 10.00-10.45 Quinolones Diarmaid Hughes, UAC, Uppsala University, Sweden 10.45-11.05 Coffee break 11.05-11.50 Targeting bacterial membranes Klaas Martinus Pos, Goethe University Frankfurt, Germany 11.50-12.45 Lunch 12:45-13:45 Poster session II - no. 15-27 3 poster walks in groups (5 min presentation + 5 min questions) in parallel: 15-19, 20-23, 24-27 - see Poster Sessions (page 82-85) 13.45-14.30 Free poster viewing of posters of the day 14.30-14.45 Coffee break Chair persons: Diarmaid Hughes and Carl-Fredrik Flach 14.45-15.30 Detection of resistance mechanisms Christian Giske, Karolinska Institutet, Stockholm, Sweden 15.30-16.15 Rapid diagnostics - Antibiotic susceptibility testing Johan Elf, Uppsala University, Sweden 16.15-16.30 Break 16.30-17.15 Structure-function of efflux systems and inhibitors Klaas Martinus Pos, Goethe University Frankfurt, Germany 17.15-18.00 Genetics behind antibiotic resistance Didier Mazel, Pasteur Institute, Paris, France 18.15-20.00 Dinner Chair person: Michael Koomey 20.00 - Evening talk Public awareness of antibiotic resistance and how media influence understanding and engagement Adam Shehata, CARe, University of Gothenburg, Sweden 5

Program Thursday 29 November Chair persons: Christina Stallings and Michael Koomey 08.30-09.15 Omics in diagnostics/detection of novel resistance genes Erik Kristiansson, CARe, Chalmers University of Technology, Gothenburg, Sweden Origins of resistance genes, selection, biological cost and compensation 09.15-09.45 The environment as a source for resistance genes Joakim Larsson, CARe, University of Gothenburg, Sweden 09.45-10.05 Coffee break 10.05-11.05 Mutations, selection (including co-selection), biological cost, compensation Diarmaid Hughes, UAC, Uppsala University, Sweden Pål Johnsen, University of Tromsö, Norway 11.05-11.50 Epistatic interactions/mutations that confer resistance to commonly used antibiotics Isabel Gordo, Instituto Gulbenkian de Ciência, Oeira, Portugal 11.50-12:45 Lunch 12:45-13:45 Poster session III - no. 28-40 3 poster walks in groups (5 min presentation + 5 min questions) in parallel: 28-32, 33-36, 37-40 - see Poster Sessions (page 82-85) 13.45-14.30 Free poster viewing of posters of the day 14.30-14.45 Coffee break Chair persons: Michael Koomey and Raimonda Viburiene 14.45-15.30 The challenges of discovering new antibiotics active on Gram-negative bacteria Eric Bacque, Evotec ID Lyon, France 15.30-16.15 Natural products Mark Brönstrup, Department of Chemical Biology, Helmholtz Centre for Infection Research, Braunschweig; Germany 16.15-16.30 Break Chair persons: Isabel Gordo and Åke Forsberg 16.30-17.00 Biofilm and targeting biofilm Ute Römling, Karolinska Institutet, Stockholm, Sweden 17.00-17.30 Targeting virulence Fredrik Almqvist, UCMR, Umeå University, Sweden 17.30-18.15 Development of novel antimicrobials acting in synergy with antibiotics Christina Stallings, Washington University, St Louis, USA 18.30-20.30 Course dinner 20.30 - Free time 6

Friday 30 November Program Antibiotic development and approval, key elements and optimizing leads Chair persons: Sanna Koskiniemi and Carl-Fredrik Flach 08.30-09.30 Antibiotic development at small and average sized companies Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria (CE- FAIA,) and Sven Bergström, QureTechBio, Umeå, Sweden 09.30-10.00 Developing pharmacokinetic and pharmacodynamic models for novel antibiotics Lena Friberg, Uppsala University, Sweden 10.00-10.30 National infrastructures for screening and drug development in Sweden Erik Chorell, CBCS/LCBU, SciLifeLab, Umeå University, Sweden 10.30-11.00 Coffee break Chair persons: Sven Bergström and Michael Koomey 11.00-11.30 Persisters/microbial antagonism Sanna Koskiniemi, Uppsala University, Sweden 11.30-12.00 In vivo studies of transcriptional reprogramming during persistent infection-implications for resistance Maria Fällman, MIMS, UCMR, Umeå University, Sweden 12.00-12.45 Panel discussion on persistence/resistance Sanna Koskiniemi and Maria Fällman 12.45-13.45 Lunch Chair persons : Maria Fällman and Raimonda Viburiene 13.45-14.30 Microbiome based strategies for decolonization of multidrug resistance and infection prevention Reetta Satokari, University of Helsinki, Finland 14.30-15.15 Future perspectives on infection prevention and alternatives to antibiotics Marc Bonten, University Medical Centre Utrecht, The Netherlands 15.15-15.45 Concluding remarks and on-line evaluation Åke Forsberg, NDPIA, Michael Koomey, IBA 16.15 Departure, bus to Landvetter airport (ca 15 minutes) 7